Volume : 08, Issue : 08, August – 2021
Title:
46.KNOWLEDGE, ATTITUDE, AND PRACTICES OF DRUG ALLERGY AMONG PRIMARY HEALTHCARE PHYSICIANS IN TAIF, KSA, 2021
Authors :
Ahmad Hameed Allehaiby, Talal Almalki
Abstract :
Introduction: Drug allergy (DA) has a critical impact on patients’ health. The reactions are unexpected; they range from a critical emergency case that may necessitate hospitalization to adjustments in subsequent therapy. Methodology: This was a cross-sectional study conducted to assess the knowledge, attitudes, and practices of drug-allergy reactions in primary health care physicians in Taif city, Saudi Arabia. All physicians working in 19 PHC in Taif city were included in this study. A self-administrated questionnaire was used for data collection. Results: A total of 128 physicians were included in this study, 57.8% were males, and most of them (75%) were Saudi. The mean score of knowledge was (59.5±16.9), attitude (62.7±9.9), and practice (68.1±16.2). Gender was significantly associated with the participants’ knowledge (P=0.048), attitude (P=0.000), and practice (P=0.001). The educational level was significantly associated with the knowledge score (P=0.003) and attitude score (P=0.003). The title was significantly associated with the participants’ knowledge (P=0.033), attitude (P=0.004), and practice (P=0.041). The nationality was significantly associated with the participants’ attitudes (P=0.000), and there was a significant association between smoking status and practice (P=0.021). Conclusion: This study demonstrated relatively good knowledge levels and positive attitudes as well as good practices towards DA among primary care physicians in Taif, Saudi Arabia. Males and consultants were the most knowledgeable, had the most positive attitudes, and best practices regarding DA.
Keywords: Drug allergy; Drug hypersensitivity reactions; Knowledge; Attitude; Practice
Cite This Article:
Please cite this article in press Ahmad Hameed Allehaiby et al., Knowledge, Attitude, And Practices Of Drug Allergy Among Primary Healthcare Physicians In Taif, Ksa, 2021., Indo Am. J. P. Sci, 2021; 08(08).
Number of Downloads : 10
References:
1. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, Khan DA, Lang DM, Park HS, Pichler W, SanchezBorges M, Shiohara T, Thong BY. International Consensus on drug allergy. Allergy 2014;69:420-37.
2. Demoly P, Pichler W, Pirmohamed M, Romano A. Important questions in allergy: 1–drug allergy/hypersensitivity. Allergy 2008;63:616-9.
3. Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P. Selfreported drug allergy in a general adult Portuguese population. Clin Exp Allergy 2004;34:1597-601.
4. Mittmann N, Knowles SR, Gomez M, Fish JS, Cartotto R, Shear NH. Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf 2004;27:477- 87.
5. Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugue P, Friedmann PS, English JS, Huber PA, Nasser SM; BSACI. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 2009;39:43-61.
6. Scherer K, Bircher AJ. Danger signs in drug hypersensitivity. Med Clin North Am 2010;94:681-9.
7. Cernadas JR, Brockow K, Romano A, Aberer W, Torres MJ, Bircher A, Campi P, Sanz ML, Castells M, Demoly P, Pichler WJ; European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. General considerations on rapid desensitization for drug hypersensitivity: a consensus statement. Allergy 2010;65:135766.
8. Mertes PM, Malinovsky JM, Jouffroy L; Working Group of the SFAR and SFA, Aberer W, Terreehorst I, Brockow K, Demoly P; ENDA; EAACI Interest Group on Drug Allergy. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011;21:442-53.
9. Li W, Zhu LL, Zhou Q. Safe medication use based on knowledge of information about contraindications concerning cross allergy and comprehensive clinical intervention. Ther Clin Risk Manag 2013;9:6572.
10. Schultz LJ, Ettling M, Chitsulo L, Steketee RW, Nyasulu Y, Macheso A, Nwanyanwu OC. A nation-wide malaria knowledge, attitudes and practices survey in Malawi: objectives and methodology. Trop Med Parasitol 1994;45:54-6.
11. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I; ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013;68:702-12.
12. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5: 309– 316
13. Yin Wang, Rongfei Zhu*, Nan Huang, Wenjing Li, Lin Yang, Shucheng Zhang, and Guanghui Liu Knowledge, attitudes, and practices survey of drug allergy among healthcare practitioners in central China: a multicenter study DOI: 10.5415/apallergy.2016.6.2.105
14. Emirate of Makkah province. Taif homepage – updated 2014 [ last updated on 2021] . Available from : https://www.makkah.gov.sa/page/taif.
15. Angamo MT, Curtain CM, Chalmers L, Yilma D, Bereznicki L. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study. PloS one. 2017 Oct 16;12(10):e0186631.
16. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15-19
17. Angamo MT, Chalmers L, Curtain CM, Bereznicki LR. Adversedrug- reaction-related hospitalisations in developed and developing countries: a review of prevalence and contributing factors. Drug Saf. 2016;39:847-857.
18. Thong BY, Mirakian R, Castells M, Pichler W, Romano A, Bonadonna P, Diana D, Kowalski M, Yanez A, Lleonart R, Sanchez-Borges M. A world allergy organization international survey on diagnostic procedures and therapies in drug allergy/hypersensitivity. World Allergy Organization Journal. 2011 Jan 1;4(12):257-70.
19. Haines HM, Meyer JC, Summers RS, Godman BB. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district. European journal of clinical pharmacology. 2020 Jul;76(7):991-1001.
20. Kunnoor NS, Lohit K. Perception of doctors towards adverse drug reaction (ADR) reporting: a cross sectional survey using a validated questionnaire. Int J Basic Clin Pharmacol Ther. 2017 Oct 25;6:2671-5.
21. Tew MM, Teoh BC, Mohd Baidi AS, Saw HL. Assessment of knowledge, attitude and practices of adverse drug reaction reporting among doctors and pharmacists in primary healthcare. Advances in Pharmacoepidemiology and Drug Safety. 2016;5(4):1-6.
22. Amrain M, Bečić F. Knowledge, perception, practices and barriers of healthcare professionals in Bosnia and Herzegovina towards adverse drug reaction reporting and pharmacovigilance. Journal of Health Sciences. 2014 Sep 27;4(2):120-5.
23. Le TT, Nguyen TT, Nguyen C, Tran NH, Tran LA, Nguyen TB, Nguyen N, Nguyen HA. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. Journal of clinical pharmacy and therapeutics. 2020 Feb;45(1):122-7.
24. Bhagavathula AS, Elnour AA, Jamshed SQ, Shehab A. Health professionals’ knowledge, attitudes and practices about pharmacovigilance in India: a systematic review and meta-analysis. PloS one. 2016 Mar 24;11(3):e0152221.
25. Paveliu MS, Bengea-Luculescu S, Mihai TO, Paveliu SF. Perception on adverse drug reaction reporting by physicians working in southern Romania. Maedica. 2013 Mar;8(1):17.
26. Abubakar AR, Simbak NB, Haque M. A systematic review of knowledge, attitude and practice on adverse drug reactions and pharmacovigilance among doctors. J Appl Pharm Sci. 2014 Oct 30;4(11):117-27.
27. Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY World Allergy Organization. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011;127:587–593.e1-22.
28. Lopez-Gonzalez E, Herdeiro MT, Piñeiro-Lamas M, Figueiras A. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug safety. 2015 Feb;38(2):189-96.
29. Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P. A novel scheme for the reporting of adverse drug reactions. Archives of disease in childhood. 2001 Apr 1;84(4):337-9.
30. Gony M, Badie K, Sommet A, Jacquot J, Baudrin D, Gauthier P, Montastruc JL, Bagheri H. Improving adverse drug reaction reporting in hospitals. Drug safety. 2010 May;33(5):409-16.
31. Consellerı´a de Sanidade. Sistema Sanitario de Galicia. Memoria 2006. Santiago de Compostela (Spain): Xunta de Galicia, 2008. Available at: www.sergas.es. [Accessed July, 2021].